SCHEMBL416819

SCHEMBL416819

CC(C)(C)c1ccc(-c2nnc(-c3cccc4ccccc34)[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 4/20 0.50
TNKS2 Q9H2K2 4/20 0.50
HDAC6 Q9UBN7 1/20 0.48
SCD O00767 1/20 0.44
CCR4 P51679 1/20 0.41
ALOX5 P09917 1/20 0.40
KDR P35968 1/20 0.40
PARP1 P09874 2/20 0.39
MAPK13 O15264 1/20 0.39
GCGR P47871 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
S1PR1 P21453 1/20 0.39
GNRHR P30968 1/20 0.38
NR1I2 O75469 1/20 0.38
LMNA P02545 1/20 0.38
ADRA2A P08913 1/20 0.38
CYP2D6 P10635 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186872 0.81 PI4KA (0.49) MAPK13GCGRMAPK12MAPK11MAPK14
SCHEMBL1023160 0.80 PPARG (0.53) TNKSTNKS2HDAC6CCR4NR1I2
SCHEMBL416514 0.80 HDAC6 (0.56) TNKSTNKS2HDAC6SCDPARP1
SCHEMBL24317556 0.79 PI4KA (0.47) MAPK13GCGRMAPK12MAPK11MAPK14
SCHEMBL12110571 0.78 MAPK14 (0.40) ALOX5MAPK13GCGRMAPK12MAPK11
SCHEMBL416418 0.78 HDAC6 (0.54) TNKSTNKS2HDAC6SCDPARP1
SCHEMBL28898889 0.77 L3MBTL1 (0.44) TNKSTNKS2ALOX5PARP1MAPK13
SCHEMBL19862833 0.76 RAB9A (0.49) TNKSTNKS2HDAC6CCR4NR1I2
SCHEMBL6374841 0.74 NPC1 (0.51) CCR4KDRS1PR1NR1I2LMNA
SCHEMBL1226979 0.74 S1PR1 (0.66) S1PR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US claimed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US claimed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 TNKS 1569/4885TNKS2 1889/4885HDAC6 767/4885
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 TNKS 1569/4885TNKS2 1889/4885HDAC6 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.